3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
2
Not yet recruiting
1
Sponsor Class
OTHER
2
OTHER_GOV
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other neoplasm
2
Conditions
Breast Neoplasms
1397
Neoplasms
1129
Prostatic Neoplasms
744
Lung Neoplasms
619
Colorectal Neoplasms
596
Carcinoma, Non-Small-Cell Lung
569
Carcinoma, Hepatocellular
413
Pancreatic Neoplasms
402
Leukemia, Myeloid, Acute
398
Stomach Neoplasms
355
Multiple Myeloma
326
Brain Neoplasms
311
Ovarian Neoplasms
309
Head and Neck Neoplasms
289
Neoplasm Metastasis
273
Precursor Cell Lymphoblastic Leukemia-Lymphoma
260
Rectal Neoplasms
253
Uterine Cervical Neoplasms
248
Recurrence
248
Melanoma
242
Esophageal Neoplasms
237
Glioblastoma
232
Squamous Cell Carcinoma of Head and Neck
231
Lymphoma
213
Sarcoma
207
Urinary Bladder Neoplasms
192
Colonic Neoplasms
192
Glioma
191
Triple Negative Breast Neoplasms
188
Hematologic Neoplasms
183
Interventions
trametinib
1
dabrafenib
1
Surgical Procedures, Operative
1
Pharmaceutical Preparations
1
Imatinib Mesylate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
OTHER
×
Rare Malignant Neoplasm
×
Clear all
NCT06119789
2025-03-26
MATRIX-Rare
Oslo University Hospital
Phase 2
Recruiting
96 enrolled
NCT06872853
2025-03-12
RAC
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Recruiting
1,100 enrolled